Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
A double-blind randomized phase II trial to evaluate Broad-spectrum antibiotics (ATB) + Inulin (inulin 32 g/day, inulin 16 g/day), and Broad-spectrum antibiotics (ATB) in patients with Infections in the Intensive Care Unit (Sepsis)
Outcome measures:
Change in Short-Chain Fatty Acids (SCFAs)-Producing Bacteria level, MDR infections, MDR organisms colonization status
…